109 related articles for article (PubMed ID: 8991806)
1. The alpha 1-adrenoceptor agonist, SDZ NVI-085, behaves as a potent, competitive antagonist of 5-hydroxytryptamine-induced contraction of rat aorta.
Van der Graaf PH; Apaydin S; Saxena PR
Eur J Pharmacol; 1995 Dec; 287(3):309-12. PubMed ID: 8991806
[TBL] [Abstract][Full Text] [Related]
2. The adrenoceptor agonist, SDZ NVI 085, discriminates between alpha 1A- and alpha 1B-adrenoceptor subtypes in vas deferens, kidney and aorta of the rat.
Eltze M; Boer R
Eur J Pharmacol; 1992 Dec; 224(2-3):125-36. PubMed ID: 1361446
[TBL] [Abstract][Full Text] [Related]
3. SDZ NVI 085, an alpha 1A-adrenoceptor agonist with 5-HT2A receptor antagonist properties.
Lachnit WG; Ford AP; Clarke DE
Eur J Pharmacol; 1996 Feb; 297(1-2):83-6. PubMed ID: 8851170
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the alpha 1-adrenoceptor subtype mediating contraction of guinea-pig spleen.
Eltze M
Eur J Pharmacol; 1994 Aug; 260(2-3):211-20. PubMed ID: 7988645
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a 5-HT1D receptor-mediated hypothermic effect of the alpha 1-adrenoceptor agonist, SDZ NVI-085, in guinea-pigs.
Kalkman HO; Neumann V
Eur J Pharmacol; 1995 Oct; 285(3):313-5. PubMed ID: 8575520
[TBL] [Abstract][Full Text] [Related]
6. Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity.
Wada T; Hasegawa Y; Ono H
Eur J Pharmacol; 1997 Dec; 340(1):45-52. PubMed ID: 9527505
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological activity of (-)-discretamine, a novel vascular alpha-adrenoceptor and 5-hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens.
Ko FN; Yu SM; Su MJ; Wu YC; Teng CM
Br J Pharmacol; 1993 Oct; 110(2):882-8. PubMed ID: 7902181
[TBL] [Abstract][Full Text] [Related]
8. Investigation of the subtypes of alpha 1-adrenoceptor mediating contractions of rat aorta, vas deferens and spleen.
Aboud R; Shafii M; Docherty JR
Br J Pharmacol; 1993 May; 109(1):80-7. PubMed ID: 8098642
[TBL] [Abstract][Full Text] [Related]
9. Functional evidence for an alpha 1B-adrenoceptor mediating contraction of the mouse spleen.
Eltze M
Eur J Pharmacol; 1996 Sep; 311(2-3):187-98. PubMed ID: 8891599
[TBL] [Abstract][Full Text] [Related]
10. Characterization of alpha1-adrenoceptor subtypes mediating contractions to phenylephrine in rat thoracic aorta, mesenteric artery and pulmonary artery.
Hussain MB; Marshall I
Br J Pharmacol; 1997 Nov; 122(5):849-58. PubMed ID: 9384500
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological activity of DC-015, a novel potent and selective alpha 1-adrenoceptor antagonist.
Yen MH; Sheu JR; Peng IH; Lee YM; Chern JW
J Pharm Pharmacol; 1996 Jan; 48(1):90-5. PubMed ID: 8722503
[TBL] [Abstract][Full Text] [Related]
12. The relationship between density of alpha-adrenoceptor binding sites and contractile responses in several porcine isolated blood vessels.
Wright IK; Blaylock NA; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Feb; 114(3):678-88. PubMed ID: 7735695
[TBL] [Abstract][Full Text] [Related]
13. Is SDZ NVI-085 an alpha 1-adrenoceptor subtype-selective agonist?
Büscher R; Insel PA; Michel MC
Life Sci; 1994; 54(14):999-1007. PubMed ID: 7908116
[TBL] [Abstract][Full Text] [Related]
14. The pharmacology of RS-15385-197, a potent and selective alpha 2-adrenoceptor antagonist.
Brown CM; MacKinnon AC; Redfern WS; Hicks PE; Kilpatrick AT; Small C; Ramcharan M; Clague RU; Clark RD; MacFarlane CB
Br J Pharmacol; 1993 Feb; 108(2):516-25. PubMed ID: 8095420
[TBL] [Abstract][Full Text] [Related]
15. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
Akers I; Coates J; Drew GM; Sullivan AT
Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological evaluation of ocoteine, isolated from Cassytha filiformis, as an alpha 1-adrenoceptor antagonist in rat thoracic aorta.
Chang CW; Ko FN; Su MJ; Wu YC; Teng CM
Jpn J Pharmacol; 1997 Mar; 73(3):207-14. PubMed ID: 9127815
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies.
Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM
Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological evaluation of N-methyl-actinodaphnine, a new vascular alpha-adrenoceptor antagonist, isolated from Illigera luzonensis.
Guh JH; Ko FN; Yu SM; Wu YC; Teng CM
Eur J Pharmacol; 1995 Jun; 279(1):33-41. PubMed ID: 7556380
[TBL] [Abstract][Full Text] [Related]
19. Mediation of noradrenaline-induced contractions of rat aorta by the alpha 1B-adrenoceptor subtype.
Testa R; Guarneri L; Poggesi E; Simonazzi I; Taddei C; Leonardi A
Br J Pharmacol; 1995 Feb; 114(4):745-50. PubMed ID: 7773533
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT and alpha-adrenoceptor antagonist effect of four benzylisoquinoline alkaloids on rat aorta.
Catret M; Ivorra MD; D'Ocón MP; Anselmi E
J Pharm Pharmacol; 1998 Mar; 50(3):317-22. PubMed ID: 9600725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
